The phrase "analysis the rates of" is not correct in English.
Did you mean "analyze the rates of"? You can use the corrected phrase when discussing the examination or evaluation of various rates in a specific context, such as finance, statistics, or research.
Example: "In our report, we will analyze the rates of customer satisfaction over the past year."
Alternatives: "examine the rates of" or "evaluate the rates of".
And according to one cost-benefit analysis the rates of return are £173 for every £1 spent – an almost unbelievably high multiple, among the very highest available for any development project.
In the macrotube agglutination analysis, the rates of L. interrogans serovar icterohaemorragia and L. interrogans serovar autumnalis were 64.9%% (n = 24) and 35.1 % (n = 13), respectively.
In univariate analysis, the rates of CIA were 44.87% for the FEC regimen, 30.30% for the TE regimen and 23.08% for the NE regimen (P = 0.068).
Similar to our results, they observed negative selection favoring the Cn nucleotides; however, in their analysis, the rates of the Nc→Cn substitutions were indistinguishable from the neutral rates.
However, on longitudinal analysis, the rates of change for both MAB and TNB increased progressively across the four PDOC groups (from VS to Emerged) confirming that the trajectory of change is an important indicator of eventual outcome with respect to recovered awareness.
In clinical analysis, the rate of therapeutic failure was 36% (4 11), with a strong association with inoculum effect (p = 0.02).
In pharmacological analysis, the rate of PK PD target non-attainment was 64%, with a strong association with CrCL (p = 0.001) (Table 1).
In our present analysis, the rate of thrombosis associated with dual-lumen cannulas was not significantly different from other cannulation types and occurred in 4/11 cases (36.4 %).
The enzymatic assay was performed following through a spectrophotometric analysis the rate of hydrolysis of N-succinyl-Ala-Ala-cis-trans-Pro-Phe-p-nitroanilide by chymotrypsin, as previously reported [53].
Specifically, in the primary efficacy analysis, the rate of new HIV infection was 4.5 per 100 person-years in the 0.5% PRO 2000 arm compared to 4.3 in the placebo arm.
In the intention to treat analysis, the rate of early treatment failure was high in all three groups (AS+AQ 13.3%; AL 15.2%; and AS+CD 9.3%, p = 0.2) primarily due to vomiting.
